Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration

Journal of Experimental Medicine

Volumn 185, Issue 11, 1997, Pages 1951-1958

  Mühlradt, Peter F ^a   Kieß, Michael ^a   Meyer, Holger ^a   Süßmuth, Roderich ^b   Jung, Günther ^b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPEPTIDE; MACROPHAGE ACTIVATING FACTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; MACROPHAGE ACTIVATION; MOUSE; MYCOPLASMA HOMINIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; MOLECULAR WEIGHT; MYCOPLASMA FERMENTANS; NITRIC OXIDE; OLIGOPEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0345671672     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.11.1951     Document Type: Article

References (52)

1. Ruuth, E., and F. Praz. 1989. Interactions between mycoplasmas and the immune system. Immunol. Rev. 112:133-160.
2. Mühlradt, P.F., H. Quentmeier, and E. Schmitt. 1991. Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product. Infect. Immun. 59: 3962-3968.
3. Feng, S.-H., and S.-C. Lo. 1994. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect. Immun. 62:3916-3921.
4. Yang, G., F.D. Coffman, and E.F. Wheelock. 1994. Characterization and purification of a macrophage-triggering factor produced in Mycoplasma arginini-infected L5178Y cell cultures. J. Immunol. 153:2579-2591.
5. Horner, P.J., C.B. Gilroy, B.J. Thomas, R.O.M. Naidoo, and D. Taylor-Robinson. 1993. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet. 342: 582-585.
6. Jensen, J.S., R. Orsum, B. Dohn, S. Uldum, A.-M. Worm, and K. Lind. 1993. Mycoplasma genitalium: a cause of male urethritis? Genitourin. Med. 69:265-269.
7. Cole, B.C., L.R. Washburn, and D. Taylor-Robinson. 1985. Mycoplasma-induced arthritis. In The Mycoplasmas. S. Razin and M.F. Barile, editors. Academic Press, Orlando. 107-160.
8. Barile, M.F., H. Yoshida, and H. Roth. 1991. Rheumatoid arthritis: new findings on the failure to isolate or detect mycoplasmas by multiple cultivation or serologic procedures and a review of the literature. Rev. Infect. Dis. 13:571-582.
9. Schaeverbeke, T., C.B. Gilroy, C. Bébéar, J. Dehais, and D. Taylor-Robinson. 1996. Mycoplasma fermentans in joints of patients with rheumatic arthritis and other joint disorders. Lancet. 347:1418.
10. Lo, S.-C., M.S. Dawson, D.M. Wong, P.B. Newton, M.A. Sonoda, W.F. Engler, R.Y. Wang, J.W.K. Shih, H. Alter, and D.J. Wear. 1989. Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study. Am. J. Trop. Med. Hyg. 41:601-616.
11. Lo, S.-C., M.M. Hayes, R.Y.-H. Wang, P.F. Pierce, H. Kotani, and J.W.K. Shih. 1991. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet. 338:1415-1418.
12. Henderson, B., S. Poole, and M. Wilson. 1996. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60:316-341.
13. Fauci, A.S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature (Lond.). 384:529-534.
14. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J. Exp. Med. 142:473-482.
15. Quentmeier, H., E. Schmitt, H. Kirchhoff, W. Grote, and P.F. Mühlradt. 1990. Mycoplasma fermentans-derived high molecular weight material induces interleukin-6 release in cultures of murine macrophages and human monocytes. Infect. Immun. 58:1273-1280.
16. Staber, F.G., R.H. Gisler, G. Schumann, L. Tarcsay, E. Schläfli, and P. Dukor. 1978. Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components) in vitro. Cell. Immunol. 37:174-187.
17. Baschang, G. 1989. Muramylpeptides and lipopeptides: studies towards immunostimulants. Tetrahedron. 45:6331-6360.
18. Bodel, P., and E. Atkins. 1967. Release of endogenous pyrogen by human monocytes. N. Engl. J. Med. 276:1002-1008.
19. Mizel, S.B., J.J. Oppenheim, and D.L. Rosenstreich. 1978. Characterization of lymphocyte-activating factor (LAP) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS. J. Immunol. 120:1504-1508.
20. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60: 3664-3672.
21. Hoffmann, P., S. Heinle, U.F. Schade, H. Loppnow, A.J. Ulmer, H.-D. Flad, G. Jung, and W. Bessler. 1988. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology. 177: 158-170.
22. Loewenstein, J., S. Rottem, and R. Gallily. 1983. Induction of macrophage-mediated cytolysis of neoplastic cells by mycoplasmas. Cell. Immunol. 77:290-297.
23. Cole, B.C., K.L. Knudtson, A. Oliphant, A.D. Sawatzke, A. Pole, M. Manohar, L.S. Benson, E. Ahmed, and C.L. Atkin. 1996. The sequence of the Mycoplasma arthritidis superantigen MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens. J. Exp. Med. 183:1105-1110.
24. Mühlradt, P.F., and M. Frisch. 1994. Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, TNF, and IL-6. Infect. Immun. 62:3801-3807.
25. Salman, M., I. Deutsch, M. Tarshish, Y. Naot, and S. Rottern. 1994. Membrane lipids of Mycoplasma fermentans. FEMS Microbiol. Lett. 123:255-260.
26. Herbelin, A., E. Ruuth, D. Delorme, C. Michel-Herbelin, and F. Praz. 1994. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect. Immun. 62:4690-4694.
27. Kostyal, D.A., G.H. Butler, and D.H. Beezhold. 1994. A 48-kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes. Infect. Immun. 62: 3793-3800.
28. Rawadi, G., and S. Roman-Roman. 1996. Mycoplasma membrane lipoproteins induce proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun. 64:637-643.
29. Mühlradt, P.F., H. Meyer, and R. Jansen. 1996. Identification of S-(2,3-dihydroxypropyl)cysteine in a macrophage-activating lipopeptide from Mycoplasma fermentans. Biochem. 35:7781-7786.
30. Mühlradt, P.F., and U. Schade. 1991. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits. Infect. Immun. 59:3969-3974.
31. Ruschmeyer, D., H.J. Thude, and P.F. Mühlradt. 1993. MDHM, a macrophage-activating product from Mycoplasma fermentans, stimulates murine macrophages to synthesize nitric oxide and become tumoricidal. FEMS Immunol. Med. Microbiol. 7:223-230.
32. Frisch, M., G. Gradehandt, and P.F. Mühlradt. 1996. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-β, type I interferon, prostaglandins or nitric oxide. Eur J. Immunol. 26:1050-1057.
33. Radolf, J.D., L.L. Arndt, D.R. Akins, L.L. Curetty, M.E. Levi, Y. Shen, L.S. Davis, and M.V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic peptides activate monocytes/macrophages. J. Immunol. 154:2866-2877.
34. Braun, V., and H.C. Wu. 1994. Lipoproteins, structure, function, biosynthesis and model for protein export. In Bacterial Cell Wall. J.-M. Ghuysen and R. Hakenbeck, editors. Elsevier Science, Amsterdam. 319-341.
35. Dong, Z., X. Qi, and I. Fidler. 1993. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J. Exp. Med. 177:1071-1077.
36. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
37. Lowry, O.H., N.R. Roberts, K.Y. Leiner, M.L. Wu, and A.L. Farr. 1954. The quantitative histochemistry of brain. I. Chemical methods. J. Biol. Chem. 207:1-17.
38. Hewick, R.M., M.W. Hunkapiller, L.E. Hood, and W.J. Dreyer. 1981. A gas-liquid solid phase peptide and protein sequenator. J. Biol. Chem. 256:7990-7997.
39. Cohen, S.L., and B.T. Chait. 1996. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal. Chem. 68:31-37.
40. Metzger, J.W., K.-H. Wiesmüller, and G. Jung. 1991. Synthesis of N-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis. Int. J. Pep. Protein. Res. 38:545-554.
41. Metzger, J.W., A.G. Beck-Sickinger, M. Loleit, M. Eckert, W.G. Bessler, and G. Jung. 1995. Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation. J. Pept. Sci. 3:184-190.
42. Theiss, P.M., M.F. Kim, and K.S. Wise. 1993. Differential expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans. Infect. Immun. 61:5123-5128.
43. Hantke, K., and V. Braun. 1973. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur. J. Biochem. 34:284-296.
44. Jung, G., K.-H. Wiesmüller, G. Becker, H.-J. Bühring, and W.G. Bessler. 1985. Increased production of specific antibodies by presentation of the antigen determinants with covalently coupled lipopeptide mitogens. Angew. Chem. Int. Ed. Engl. 24:872-873.
45. Shimizu, T., Y. Iwamoto, Y. Yanagahira, M. Kurimura, and K. Achiwa. 1994. Mitogenic activity and the induction of tumor necrosis factor by lipopeptide analogs of the N-terminal part of lipoprotein in the outer membrane of Escherichia coli. Biol. Pharm. Bull. 17:980-982.
46. Wiesmüller, K.-H., G. Jung, and G. Hess. 1989. Novel low-molecular weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine. 7:29-33.
47. Wiesmüller, K.-H., W. Bessler, and G. Jung. 1992. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope specific B-, T-helper and T-killer cell response. Int. J. Pep. Protein Res. 40:255-266.
48. Deres, K., H.-J. Schild, K.-H. Wiesmüller, G. Jung, and H.-G. Rammensee. 1989. In vivo priming of virus specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (Lond.). 342:561-564.
49. Schild, H.-J., K. Deres, K.-H. Wiesmüller, G. Jung, and H.-G. Rammensee. 1991. Efficiency of peptides and lipopeptides for in vivo priming of virus specific cytotoxic T-cells. Eur. J. Immunol. 21:2649-2654.
50. Borges, E., K.-H. Wiesmüller, G. Jung, and P. Walden. 1994. Efficacy of synthetic lipopeptides in the induction of cytotoxic T lymphocytes: comparison of the costimulating support provided by helper T cells and lipoaminoacid. J. Immunol. Methods. 173:253-263.
51. Himmelreich, R., H. Hilbert, H. Plagens, E. Pirkl, B.-C. Li, and R. Herrmann. 1996. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 24:4420-4449.
52. Olson, L.D., C.A. Renshaw, S.W. Shane, and M.F. Barile. 1991. Successive synovial Mycoplasma hominis isolates exhibit apparent antigenic variation. Infect. Immun. 59:3327-3329.